Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/PROTALIX-BIOTHERAPEUTICS--45401/noticia/Chiesi-Global-Rare-Diseases-y-Protalix-BioTherapeutics-Inc-Recibe-el-dictamen-positivo-del-CHMP-pa-43085380/?utm_source=whatsapp&utm_medium=social&utm_campaign=share